Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 806 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR ESMO Breast Cancer 2024, 15-17 May, Berlin, Germany May 8, 2024 Metformin May Affect Risk of Breast Cancer in Women with Type... January 28, 2021 2021 ASCO Annual Meeting: New Treatments and Research Advances in Esophageal... June 3, 2021 10 Things I Wish I Knew When I Was First Diagnosed... July 19, 2022 Load more HOT NEWS Efficacy and Safety of Elranatamab, BCMA-CD3 Bispecific Antibody, in Patients with... FDA Approves Nivolumab with Ipilimumab for Unresectable or Metastatic MSI-H or... EMA Recommends Granting a Marketing Authorisation for Relugolix One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among...
